يعرض 1,941 - 1,960 نتائج من 29,304 نتيجة بحث عن '(( 5 step decrease ) OR ( 50 ((((nn decrease) OR (teer decrease))) OR (a decrease)) ))', وقت الاستعلام: 0.99s تنقيح النتائج
  1. 1941

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease حسب Yi Sun (118759)

    منشور في 2022
    "…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …"
  2. 1942

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease حسب Yi Sun (118759)

    منشور في 2022
    "…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …"
  3. 1943

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease حسب Yi Sun (118759)

    منشور في 2022
    "…<b>SZM679</b>, a highly specific RIPK1 inhibitor (<i>K</i><sub>d,RIPK1</sub> = 8.6 nM, <i>K</i><sub>d,RIPK3</sub> > 5000 nM), was developed by our group with superior high antinecroptotic activity (EC<sub>50</sub> = 2 nM), and investigated to completely reverse the tumor necrosis factor-induced systemic inflammatory response syndrome. …"
  4. 1944
  5. 1945

    Table1_Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetic... حسب Veronika Todorovova (12157917)

    منشور في 2022
    "…Differences were also found in the effects of various APOE isoforms on lipid lowering. A significant decrease in lipid parameters was observed with the E2E2 isoform whereas a minimal decrease was seen with the E4E4 and E3E3 isoforms.…"
  6. 1946

    Image1_Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetic... حسب Veronika Todorovova (12157917)

    منشور في 2022
    "…Differences were also found in the effects of various APOE isoforms on lipid lowering. A significant decrease in lipid parameters was observed with the E2E2 isoform whereas a minimal decrease was seen with the E4E4 and E3E3 isoforms.…"
  7. 1947
  8. 1948
  9. 1949
  10. 1950
  11. 1951
  12. 1952
  13. 1953
  14. 1954
  15. 1955

    Table_4_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX حسب Yan Wang (15435)

    منشور في 2020
    "…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …"
  16. 1956

    Table_1_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX حسب Yan Wang (15435)

    منشور في 2020
    "…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …"
  17. 1957

    Table_2_Clinical Features of 50 Patients With Primary Adrenal Lymphoma.DOCX حسب Yan Wang (15435)

    منشور في 2020
    "…<p>Background and Objective: Primary adrenal lymphoma is a rare, progressive, easily misdiagnosed adrenal tumor with a poor prognosis. …"
  18. 1958
  19. 1959
  20. 1960